China - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, China Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases grew 25.7% year on year. In 2019, the country was number 5 comparing other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases with 18,246 Cases. China is overtaken by Russia, which was ranked number 4 at 27,207 Cases and is followed by South Africa at 18,080 Cases. India ranked the highest with 66,255 Cases in 2019, that is +13.6% versus 2018. Republic of the Congo witnessed the best average annual growth at +171.1% per year, while Croatia recorded the worst performance at -100% per year.
Loading...
| Date | Units (Cases) |
|---|---|
| 2019 | 18,246.00 |
| 2018 | 14,636.00 |
| 2017 | 13,069.00 |
| 2016 | 10,898.00 |
| 2015 | 9,662.00 |
Download all data from 2006 to 2019
How does China rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
| # | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
| 3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
| 5 |
#5
China
|
18,246 | 2019 | +24.7 % | +25.7 % | View data | |
| 6 |
#6
South Africa
|
18,080 | 2019 | +2.1 % | -0.7 % | View data | |